Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialLaura Guay, J. Brooks Jackson, Philippa Musoke et al.|The Lancet|1999Cited by 1.7k
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in WomenJared M. Baeten, Zeda Rosenberg, Thesla Palanee‐Phillips et al.|New England Journal of Medicine|2016Cited by 768
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trialJ. Brooks Jackson, Francis Mmiro, Thomas R. Fleming et al.|The Lancet|2003Cited by 525
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in WomenJared M. Baeten, Zeda Rosenberg, Thesla Palanee‐Phillips et al.|Obstetrical & Gynecological Survey|2016Cited by 373
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)Philippa Musoke, J. Brooks Jackson, Laura Guay et al.|AIDS|1999Cited by 217